Logo image of BNP.DE

BNP PARIBAS (BNP.DE) Stock Fundamental Analysis

FRA:BNP - Deutsche Boerse Ag - FR0000131104 - Common Stock - Currency: EUR

76.58  -0.47 (-0.61%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BNP. BNP was compared to 99 industry peers in the Banks industry. BNP may be in some trouble as it scores bad on both profitability and health. BNP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BNP was profitable.
In the past year BNP has reported a negative cash flow from operations.
Each year in the past 5 years BNP has been profitable.
In multiple years BNP reported negative operating cash flow during the last 5 years.
BNP.DE Yearly Net Income VS EBIT VS OCF VS FCFBNP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B -50B 100B

1.2 Ratios

BNP has a Return On Assets (0.86%) which is in line with its industry peers.
With an excellent Return On Equity value of 18.19%, BNP belongs to the best of the industry, outperforming 88.17% of the companies in the same industry.
Industry RankSector Rank
ROA 0.86%
ROE 18.19%
ROIC N/A
ROA(3y)0.39%
ROA(5y)0.35%
ROE(3y)8.24%
ROE(5y)7.65%
ROIC(3y)N/A
ROIC(5y)N/A
BNP.DE Yearly ROA, ROE, ROICBNP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

BNP's Profit Margin of 17.25% is on the low side compared to the rest of the industry. BNP is outperformed by 63.44% of its industry peers.
BNP's Profit Margin has improved in the last couple of years.
BNP does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 17.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.35%
PM growth 5Y5.26%
GM growth 3YN/A
GM growth 5YN/A
BNP.DE Yearly Profit, Operating, Gross MarginsBNP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

2

2. Health

2.1 Basic Checks

BNP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BNP has been reduced compared to 1 year ago.
The number of shares outstanding for BNP has been reduced compared to 5 years ago.
The debt/assets ratio for BNP has been reduced compared to a year ago.
BNP.DE Yearly Shares OutstandingBNP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
BNP.DE Yearly Total Debt VS Total AssetsBNP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T 2T 2.5T

2.2 Solvency

BNP has a Debt/Equity ratio of 2.61. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.61, BNP is in line with its industry, outperforming 43.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.61
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.03%
BNP.DE Yearly LT Debt VS Equity VS FCFBNP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BNP.DE Yearly Current Assets VS Current LiabilitesBNP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.78% over the past year.
Measured over the past years, BNP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.03% on average per year.
Looking at the last year, BNP shows a very strong growth in Revenue. The Revenue has grown by 43.09%.
Measured over the past years, BNP shows a small growth in Revenue. The Revenue has been growing by 1.62% on average per year.
EPS 1Y (TTM)13.78%
EPS 3Y13.62%
EPS 5Y9.03%
EPS Q2Q%16.44%
Revenue 1Y (TTM)43.09%
Revenue growth 3Y4.78%
Revenue growth 5Y1.62%
Sales Q2Q%11.37%

3.2 Future

The Earnings Per Share is expected to decrease by -0.39% on average over the next years.
BNP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.08% yearly.
EPS Next Y-5.17%
EPS Next 2Y3.22%
EPS Next 3Y4.89%
EPS Next 5Y-0.39%
Revenue Next Year5.04%
Revenue Next 2Y5.38%
Revenue Next 3Y5.19%
Revenue Next 5Y5.08%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BNP.DE Yearly Revenue VS EstimatesBNP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
BNP.DE Yearly EPS VS EstimatesBNP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

BNP is valuated cheaply with a Price/Earnings ratio of 7.19.
Based on the Price/Earnings ratio, BNP is valued cheaper than 83.87% of the companies in the same industry.
BNP is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.58, the valuation of BNP can be described as very cheap.
Based on the Price/Forward Earnings ratio, BNP is valued cheaper than 92.47% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, BNP is valued rather cheaply.
Industry RankSector Rank
PE 7.19
Fwd PE 7.58
BNP.DE Price Earnings VS Forward Price EarningsBNP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BNP.DE Per share dataBNP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.8
EPS Next 2Y3.22%
EPS Next 3Y4.89%

6

5. Dividend

5.1 Amount

BNP has a Yearly Dividend Yield of 6.21%, which is a nice return.
BNP's Dividend Yield is a higher than the industry average which is at 5.06.
Compared to an average S&P500 Dividend Yield of 2.33, BNP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.21%

5.2 History

The dividend of BNP is nicely growing with an annual growth rate of 11.52%!
Dividend Growth(5Y)11.52%
Div Incr Years2
Div Non Decr Years2
BNP.DE Yearly Dividends per shareBNP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

DP0%
EPS Next 2Y3.22%
EPS Next 3Y4.89%
BNP.DE Yearly Income VS Free CF VS DividendBNP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B -50B 100B

BNP PARIBAS

FRA:BNP (3/7/2025, 7:00:00 PM)

76.58

-0.47 (-0.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-04 2025-02-04/bmo
Earnings (Next)N/A N/A
Inst Owners44.4%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap86.60B
Analysts76
Price Target81.26 (6.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.21%
Yearly Dividend3.99
Dividend Growth(5Y)11.52%
DP0%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.09%
Min EPS beat(2)-0.18%
Max EPS beat(2)42.35%
EPS beat(4)3
Avg EPS beat(4)21.66%
Min EPS beat(4)-0.18%
Max EPS beat(4)42.35%
EPS beat(8)7
Avg EPS beat(8)28.26%
EPS beat(12)10
Avg EPS beat(12)23.83%
EPS beat(16)14
Avg EPS beat(16)21.83%
Revenue beat(2)1
Avg Revenue beat(2)0.59%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)2.73%
Revenue beat(4)3
Avg Revenue beat(4)1.15%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)2.73%
Revenue beat(8)4
Avg Revenue beat(8)-0.28%
Revenue beat(12)7
Avg Revenue beat(12)31.37%
Revenue beat(16)11
Avg Revenue beat(16)46.24%
PT rev (1m)3.95%
PT rev (3m)2.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)1.17%
EPS NY rev (3m)-1.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)0.45%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 7.19
Fwd PE 7.58
P/S 0.64
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.73
EV/EBITDA N/A
EPS(TTM)10.65
EY13.91%
EPS(NY)10.1
Fwd EY13.19%
FCF(TTM)-88
FCFYN/A
OCF(TTM)-86.11
OCFYN/A
SpS119.52
BVpS113.31
TBVpS104.52
PEG (NY)N/A
PEG (5Y)0.8
Profitability
Industry RankSector Rank
ROA 0.86%
ROE 18.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 17.25%
GM N/A
FCFM N/A
ROA(3y)0.39%
ROA(5y)0.35%
ROE(3y)8.24%
ROE(5y)7.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.35%
PM growth 5Y5.26%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 2.61
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.37%
Cap/Sales 1.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC5.03%
ROIC/WACCN/A
Cap/Depr(3y)34.56%
Cap/Depr(5y)28.09%
Cap/Sales(3y)3.27%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.78%
EPS 3Y13.62%
EPS 5Y9.03%
EPS Q2Q%16.44%
EPS Next Y-5.17%
EPS Next 2Y3.22%
EPS Next 3Y4.89%
EPS Next 5Y-0.39%
Revenue 1Y (TTM)43.09%
Revenue growth 3Y4.78%
Revenue growth 5Y1.62%
Sales Q2Q%11.37%
Revenue Next Year5.04%
Revenue Next 2Y5.38%
Revenue Next 3Y5.19%
Revenue Next 5Y5.08%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-172.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-184.38%
OCF growth 3YN/A
OCF growth 5YN/A